BCM
TWST icon

Bayesian Capital Management’s Twist Bioscience TWST Stock Holding History

Bayesian Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,868
Closed -$253K – 809
2025
Q2 		$253K Buy
+6,868
New +$237K 0.04% 419
2025
Q1 		– Sell
-10,811
Closed -$502K – 970
2024
Q4 		$502K Buy
+10,811
New +$489K 0.06% 369
2024
Q3 		– Sell
-20,846
Closed -$1.03M – 1044
2024
Q2 		$1.03M Buy
20,846
+6,300
+43% +$257K 0.12% 229
2024
Q1 		$499K Buy
14,546
+4,352
+43% +$157K 0.05% 437
2023
Q4 		$376K Buy
+10,194
New +$236K 0.04% 448
2023
Q1 		– Sell
-19,975
Closed -$476K – 1095
2022
Q4 		$476K Buy
+19,975
New +$579K 0.07% 370
2022
Q2 		– Sell
-8,800
Closed -$435K – 1085
2022
Q1 		$435K Buy
+8,800
New +$488K 0.06% 411

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Bayesian Capital Management's TWST Position: Q3 2025 in Review

Bayesian Capital Management sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 6,868 shares — an estimated $253K sold.

Bayesian Capital Management first reported a position in TWST in Q1 2022 and held it in 7 quarters. The position peaked at $1.03M in Q2 2024. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • Bayesian Capital Management reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 6,868 Twist Bioscience shares in Q3 2025, an estimated $253K.
  • Bayesian Capital Management first reported a position in Twist Bioscience in Q1 2022 and held it in 7 quarters.
  • Bayesian Capital Management's Twist Bioscience position peaked at $1.03M in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.